ABSTRACT We present a novel Bayesian validation paradigm with several validation metrics tailored to biomarker discovery, including moments (the mean and variance) of the number of false discoveries, the number of missed discoveries, and the false discovery rate. All of these validation metrics can be used with a variety of Bayesian variable selection methods already available in the literature. When used in conjunction with Bayesian models with independent Gaussian features, we call these validation metrics optimal Bayesian feature filtering moments (OBFMs). We find closed-form expressions for OBFMs and show that they are asymptotically Gaussian and consistent even when the modeling assumptions are violated. In both synthetic simulations and real data analysis, OBFMs perform very well in biomarker discovery relative to other methods from the literature.
I. INTRODUCTION
The goal of biomarker discovery is to find biological markers that are clinically useful, say, for diagnosis, drug development, or personalized treatment of the disease under study [1] . While current high-throughput technologies measure tens of thousands of features per sample point, exploratory research is usually constrained to small samples [2] - [4] . In addition, many sources of error in the data, imbalanced samples, outliers, heterogeneity, and complex gene interactions make it challenging to find reliable and reproducible biomarkers [5] - [7] . Although biomarker development ideally involves some form internal validation in the initial discovery phase [5] , there are relatively few objective techniques available to provide assurances on the quality of reported gene sets. Hereafter, we refer to internal validation during discovery as simply ''validation''; this does not include verification of the reliability and reproducibility of measurements from patient specimens on clinically applicable assays, or validation of clinical utility, which are typically performed in follow-up studies or trials [5] .
Perhaps the most popular validation approach in bioinformatics is to view gene selection as a multiple comparisons
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problem and control the false discovery rate (FDR), e.g., to bound the expected proportion of uninteresting genes polluting a reported gene list. Several FDR correction methods are available, for example, the Benjamini-Hochberg (BH) step up procedure guarantees FDR is bounded by α under independent tests [11] , and a simple conservative modification of the procedure can guarantee the same bound under arbitrary dependencies [12] . Although FDR correction methods like these are powerful, they have several limitations: (1) Generally, they are designed to be used in conjunction with parallel statistical tests that output a pvalue for each feature. If a selection algorithm does not output a p-value for each feature, it is very problematic to use FDR correction. (2) FDR correction methods output a single gene set with controlled FDR, and do not provide a methodology to comment on the FDR of arbitrary sets. This is problematic if one is interested in, for instance, gene sets that map to different pathways, or single genes on their own. (3) Classically, FDR is defined to be the expected false discovery proportion (FDP) , where the FDP is the proportion of false discoveries over discoveries, and the expectation is over the sampling distribution, i.e., over hypothetical repetitions of the experiment. Although ''FDP is the quantity a researcher would really want to know in order to assess the quality of a gene list'' [13] , bounding FDR does not necessarily provide any guarantees on the FDP for the given sample and selected set in hand. Indeed, even when the FDR is bounded below α, the FDP can still have high variance or a large tail probability, and thus it can far exceed α with relatively high probability [14] , [15] . High variance is especially problematic under correlated features and small samples, which are common in bioinformatics [14] . This problem may be remedied by instead bounding the probability that the FDP exceeds a given threshold, i.e. the false exceedance rate (FDX) [16] , ''but it is not clear yet to what extent one has to give up power in practice'' [17] . Several methods also aim to estimate FDP directly [13] , [14] , for example, [18] derives an approximate expression for the FDP under arbitrary covariance dependence, which can also be used to bound FDR; however, this method requires the covariance matrix to be known.
Gene sets can also be selected or validated using stability indices, which aim to quantify how often a given feature or feature set is selected across many resampling iterations [19] . It is hoped that selection algorithms based on stability indices are robust to small perturbations and more reproducible for high-dimensional ''omics'' data [19] . Although stability indices can be computed for arbitrary feature sets, the internal resampling procedure can be computationally intensive and yield a high internal variance. Stability indices can also be significantly influenced by peculiarities of the selection algorithm used, and they do not necessarily correlate well with feature selection performance. For example, a selection algorithm that outputs a fixed feature set is indeed very stable, but this fact has no bearing on the number of false or missed discoveries in this set.
Many feature selection methods assign scores to each feature or feature set that may also be used for validation, or used in conjunction with cross validation, bootstrap, permutation tests, noise injection, or other resampling methods for validation [19] , [21] , [22] . For example, classification error estimates can be used to give a sense of the separation of classes under the selected features. However, classification-based methods tend to avoid redundant features and reward smaller feature sets to avoid overfitting or simplify model construction, which may result in missing many important potential markers. See [21] , [23] , [24] for more discussion.
Here, we propose a Bayesian paradigm for gene set validation that can remedy all of these issues. The general framework focuses on two key practical notions of ''error'': the number of false discoveries and the number of missed discoveries. Given posteriors on genes or gene sets, we characterize the sample-conditioned mean, variance, covariance, and probability mass functions (PMFs) of these errors. These sample-conditioned error moments are useful in and of themselves for validation, and we additionally show how they can be used to find Bayesian analogs of FDR, the false nondiscovery rate (FNR) [16] , the weighted FDR (W-FDR) [25] , and other validation metrics. Further, the sample-conditioned error PMFs facilitate Bayesian analogs of the family-wise error rate (FWER), k-FWER, k-FDR [25] , and FDX.
While the general framework can be implemented using any Bayesian model that outputs posteriors on genes or gene sets, we find closed form expressions for our validation metrics under a family of Gaussian models with independent features and binary labels. These models were originally proposed in [26] to derive the optimal Bayesian feature filtering (OBF) selection rule, and further studied in [27] , [28] . Whereas [26] focused on only feature selection, here we will use the model proposed in [26] to perform validation. We refer to error moments computed under these models as OBF moments (OBFMs) . OBF directly models markers as being differentially expressed between groups, and non-markers as being non-differentially expressed. Thus, OBF allows us to directly answer questions most relevant in biomarker discovery, for example, ''Which features are most likely to be markers?'' While sample-conditioned error means under OBF are not new, the error variances and PMFs under OBF presented herein are new. We also prove two important theoretical properties of OBFMs: asymptotic normality and consistency under very mild conditions.
Whether computed under OBF or another Bayesian model, our proposed validation metrics, including the Bayesian analog to FDR, can be used independently along with any selection rule, can be used to assess any gene set, are computed by conditioning on the given sample and gene set in hand (rather than by averaging over hypothetical samples or replications of the experiment), and do not require withholding any data for training. OBFMs in particular can be found with very low computation cost, similar to that of t-tests, which scales linearly with the number of features. The sampleconditioned error variances are perhaps more important than the error means, since they assess the accuracy or credibility of reported error means. Although this kind of credibility assessment is critically important, it is largely overlooked in the literature and typically absent in practice. The FNR, which is based on the sample-conditioned mean number of missed discoveries, is also interesting, given how missed discoveries have also received less attention in the literature.
Besides OBF, there are many alternative Bayesian variable selection methods available in the literature [29] - [31] . Unlike OBF, the vast majority assume a regression or classification model and impose a sparsity inducing prior on the regression coefficients. For example, maximum a posteriori (MAP) estimates of regression coefficients under linear and generalized linear models using LASSO (Laplace priors), or elastic net [32] (mixed Laplace and Gaussian priors), can usually be solved with low computation cost. However, the optimization process does not produce the full posterior, which hinders our ability to validate the selected model. Alternatively, spikeand-slab [33] and beta-binomial [34] , [35] priors may be used, but they do not have closed form posteriors, and require computationally intensive methods like Markov chain Monte Carlo (MCMC) to sample the posterior distribution. When it comes to biomarker discovery, placing priors on regression coefficients, as these methods do, is ill-advised: (1) Priors on regression coefficients are difficult to interpret in VOLUME 7, 2019 biological applications, and it is difficult to convert expert biological knowledge into such priors. (2) Gene selection is done using the posterior inclusion probabilities for each regression term, i.e., the probability that each variable has a non-zero coefficient in the ''true'' model. In biomarker discovery, one instead needs the probabilities on each variable being a marker, which can correspond to a significantly different gene set. (3) Variable selection methods based on regression or classification tend to be sensitive to the prior even under large samples [36] - [38] , unstable or sensitive to small perturbations of the data [7] , [39] , and tend to output very small gene sets and miss many markers [2] , [3] , [7] .
Shared kernel Bayesian screening (SKBS) [40] is one Bayesian method that is not based on regression. It assumes all features can be represented via a mixture of several fixed kernels, and finds the sample conditioned probability of a feature having different mixture weights between the two classes. SKBS and OBF are similar in that both are filter methods that place uncertainties on the identities of each feature, but they take different approaches to modeling the expression value distributions.
Our emphasis in the current work is not on feature selection itself, but rather on validation, which has received far less attention. Scores based on predictive densities and prediction errors have been studied in many Bayesian settings [30] , and Bayesian model assessment has been studied in engineering contexts [41] - [43] . However, these methods require a small number of variables, moderate to large samples sizes, only a few competing models, and they tend to focus on the distinction between measurement and prediction errors. Unfortunately, these settings are not characteristic of the small-sample high-dimensional biomarker discovery problem. These works also focus more on model validation, rather than feature validation. Feature validation does not aim to verify any specific model; rather, the objective is merely to evaluate the usefulness of the selected features in discriminating between groups. Model validation is much harder, since it also aims to validate interrelationships between system variables in a proposed model, for example using validation metrics that compare experimental observations with model outputs, and accurate modeling requires more data than is typically plausible in exploratory biomarker discovery. It may be obvious, even under a small sample, that a given gene is useful in discriminating between groups, while being difficult to fully model exactly how this gene functions (or malfunctions) across the whole population.
There has also been some work on Bayesian selection rules that bound FDR for the given sample [47] - [49] . One notable approach is the FDR correction method in [50] , [51] , which uses a Bayesian generalized linear model with priors on the regression coefficients. The marginal posterior of each feature is obtained using MCMC. Afterwards, these posteriors are converted to q-values using Storey's method (ST) [52] , which are then used for FDR correction. We will compare this approach (both raw posteriors plugged into our error moment equations, and the full FDR correction scheme) to OBFMs. The method in [51] suffers from the same problems as other Bayesian methods based on regression, and it also contains several tuning parameters in the prior that are not easy to interpret. Finally, Bayesian metrics such as likelihood ratios and marginal likelihoods have been used as marginal utility functions [53] , [54] in sure independence screening [55] , where they are interpreted as mere score functions.
The proposed validation theory is presented in Section II, and can be used with any posterior on feature sets. We discuss the special case of OBFMs in Section III. In Section IV, we compare error moments found using our methodology under priors from [33] , [40] , [51] , [56] , as well as OBFMs, in synthetic simulations. We also compare FDR estimates based on OBFMs with several other Bayesian and nonBayesian FDR correction methods, and compare OBFMs with stability indices. Results here suggest that OBFMs perform faster than and at least as well as other methods we examined, even when the data is correlated, non-Gaussian, or other assumptions are violated. Finally, we provide realworld examples on breast cancer and colon cancer datasets in Section V.
II. ERROR ANALYSIS
Let F be a set of feature indices. Associate each feature f ∈ F with a space, X f , and let X = f ∈F X f be the feature space. We call features we wish to select (for instance differentially expressed genes or potential biomarkers) good, and features we wish not to select (for instance non-markers or nondisease-associated genes) bad. We denote the set of all good features and all bad features byḠ andB = F\Ḡ, respectively. G andB are random; we denote their realizations by G and B, respectively, and denote the prior onḠ by π(G)
Assume we observe data S, and the probability density function (PDF) of the data givenḠ, p(S|Ḡ = G), is known. Section III presents an important example where S contains feature-label pairs supervised with binary class labels; however, the current section also applies when the data is accompanied by continuous labels or no labels, for example. We obtain a posterior π * (G)
Note that π * (f , f ) = π * (f ). Suppose a selection rule outputs the set G. Let E 1 (G,Ḡ) ≡ f ∈G 1 f ∈B = |G\Ḡ| be the number of bad features (erroneously) selected, and let E 2 (G,Ḡ) ≡ f ∈B 1 f ∈Ḡ = |Ḡ\G| be the number of good features missed, where 1 (·) is the indicator function. E 1 and E 2 are functions of G andḠ only since B = F\G andB = F\Ḡ.
Given the data and G, E 1 is a discrete random variable over integers from 0 to |G| with mean E(E 1 |S), variance var(E 1 |S), and PMF
where l = 0, . . . , |G|. Likewise, E 2 has a distribution over integers from 0 to |B| = |F| − |G| with mean E(E 2 |S), variance var(E 2 |S), and PMF
where l = 0, . . . , |B|. The following theorem provides equations for the sample-conditioned first and second-order moments of E 1 and E 2 . Theorem 1: The following hold:
var(
where summations over f and f include cases where f = f . Proof: See Appendix A. As a sample-conditioned expectation, E(E 1 |S) is the minimum mean square error (MMSE) estimator of E 1 (regularity assumptions are satisfied since E 1 is finite). Furthermore, the MMSE is precisely var(E 1 |S). That is, given S,
var(E 1 |S) quantifies uncertainty in E 1 and the performance of E(E 1 |S) as an estimator of E 1 . E(E 1 |S) is also unbiased:
All of these properties hold for E 2 as well. E(E 2 1 |S) and var(E 1 |S) are also MMSE estimators of E 2 1 and (E 1 − E(E 1 |S)) 2 , respectively. Thus, they are unbiased:
In the remainder of this section, we propose several validation metrics for Bayesian error analysis. The proposed workflow is summarized in Fig. 1 . Equation (3) and the five moments in Theorem 1 serve as building blocks. 
A. FAMILY-WISE ERROR RATE ANALYSIS
FWER is a classical validation metric that has waned in discovery applications in recent years due to its conservative nature. Here we examine FWER for the sake of being complete, and to show how versatile the Bayesian framework is for error analysis. In multiple hypothesis testing, FWER is the probability of making one or more false discoveries. For an arbitrary G ⊆ F, we define
P (E 1 = 0|S) is given by (3) with l = 0. Although FWER is conventionally defined by a probability over the sampling distribution, here the probability is overḠ and conditioned on the sample in hand. Recall that E 1 depends on the selected feature set G; while G varies with the sample under the conventional definition of FWER, in our Bayesian framework G is fixed given the sample. A generalization of FWER is k-FWER [57] , which is the probability of making at least k false discoveries. k-FWER for k = 1 reduces to FWER. For our purposes, we define
This requires P (E 1 = l|S) for l = 0, . . . , k −1, defined in (3).
B. FALSE DISCOVERY RATE ANALYSIS
FDR is the expected proportion of false discoveries among selected features. Here, we define FDR to be E(Q|S), where Q = E 1 /|G| is the FDP. Again, the expectation is overḠ and conditioned on the sample. By Theorem 1,
FNR is the expected proportion of false non-discoveries among non-selected features. Letting M = E 2 /|B|, define:
W-FDR is a generalization of FDR that assigns a weight that represents importance to each hypothesis test. FDR is a special case of W-FDR with uniform weights. In our Bayesian setting, we define W-FDR to be E(W |S), where
f ∈G w f , and w f is a weight representing the importance of feature f ∈ F being correctly labeled. Observe that, following derivations like those in Theorem 1,
Finally, k-FDR [25] is the expected proportion of k or more false discoveries among selected features, i.e.,
FDR is a special case of k-FDR with k = 0. FDR, FNR and W-FDR require π * (f ) for f ∈ F, which is defined in (1), their variances additionally require π * (f , f ) for f , f ∈ F, which is defined in (2), and k-FDR requires P (E 1 = l|S) for l = k + 1, . . . , |G|, which is defined in (3).
C. FALSE EXCEEDANCE RATE ANALYSIS
FDX is the probability that FDP exceeds a specified bound [58] . In the Bayesian setting, we define
where q is between 0 and 1. Rather than report FDX for a given q, one may also find the smallest q, call it q * , such that FDX is bounded below a given threshold, α. Thereby, one may conclude that FDP is below q * with high probability, 1 − α. In particular, q * is the smallest q such that P(E 1 /|G| > q|S) = P(E 1 > q|G||S) ≤ α. Let i * be the smallest integer i such that
Then q * = i * /|G|.
D. NUMBER OF CORRECTLY LABELED FEATURES
Rather than focus on errors, we may equivalently focus on correctly labeled features. Let
f ∈G 1 f ∈Ḡ = |G ∩Ḡ| denote the numbers of bad features not selected and good features selected, respectively. We have that E 1 + C 1 = |B|, E 2 + C 2 = |Ḡ|, E 1 + C 2 = |G|, and E 2 + C 1 = |B|. Thus,
We also have the following mixed moments:
E. RISK ANALYSIS
We may wish to merge E 1 and E 2 into a single metric. Denote the loss in reporting G whenḠ is the true good set by 
The variance of the loss is:
. E t has a distribution over integers from 0 to |F| with mean and variance
where the last line follows from (6), (8) and (9) in Theorem 1, and the fact that π * (f , f ) is a symmetric function. Other choices for λ 1 , λ 2 , λ G and λ B can be used to impose different penalties, for example setting λ 1 > λ 2 penalizes false discoveries more relative to missed discoveries, and setting λ G > λ B penalizes larger sets of discoveries more relative to smaller sets.
III. INDEPENDENT GAUSSIAN MODELS
We next present a family of Bayesian models originally proposed in [26] , where all features are independent and Gaussian. For each feature f ∈ F, let π(f ) ≡ P(f ∈Ḡ) be the prior probability that f is good. Assuming the events {f ∈Ḡ} are independent for all f ∈ F,
We also assign f three parameters, θ 
For a proper prior, s 
where is the gamma function. Likewise, let θ f = [µ f , σ f ] and p(θ f ) be normal-inverse-Wishart with hyperparameters s f , κ f , m f , and ν f , and scaling constants K f and L f .
Let S contain n labeled points with n y class y points. Given G = G, θ f y for all f ∈ G and θ f for all f ∈ B (each independently generated), and the labels (independently generated), assume sample points are independent and features are independent, such that good feature f ∈ G is Gaussian with mean µ 
andσ f are the sample means and unbiased sample variances of feature f under class y and feature f under both classes. Fig. 2 summarizes the proposed validation workflow under independent Gaussian models. We call error moments computed under these models OBFMs. Error means in (5) and (7), FDR, FNR, W-FDR, the expected number of correctly labeled features, and risk, are all easily found for independent models using the closed form π * (f ). To evaluate error variances, and variances for these validation metrics, we also require π * (f , f ). Thanks to independence between features, it can be shown that
Equation (23) also follows by noting that, under independent models given the sample, E 1 is the sum of |G| independent Bernoulli random variables with success probabilities 1 − π * (f ) for f ∈ G; thus, E 1 is Poisson binomially distributed. Likewise, (24) follows because E 2 is Poisson binomial with success probabilities π * (f ) for f ∈ B. Also, (25) follows because E 1 and E 2 are independent. The Poisson binomial PMF for E 1 is given by
FWER requires evaluating this for l = 0, which reduces to
The sum in (26) is over all subsets of G of size l, which is |G| choose l terms. Although computing this many terms is intractable unless |G| is small, as long as π * (f ) = 0 for all f ∈ G, we may use the following recursive formula for l = 1, . . . , |G| to compute the sum efficiently and greatly reduce FIGURE 2. The proposed Bayesian paradigm for gene set validation under independent Gaussian models.
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computation for k-FWER, k-FDR, and FDX [59] : (28) where P(E 1 = 0|S) is found from (27) and
This method is related to Newton's identities for polynomials. Unfortunately, this technique is not numerically stable and should be avoided if |G| is larger than about 20. Several other methods have been proposed to evaluate the PMF of Poisson binomial distributions [59] , including a method based on discrete Fourier transforms [60] . Approximation methods may also be used. For example, one may approximate P(E 1 = l|S) using a Gaussian distribution with mean E(E 1 |S) and variance var(E 1 |S) when |F| is large (this is justified by asymptotic normality, which we will discuss in Appendix B-A), or a Poisson distribution with rate parameter λ = f ∈G (1 − π * (f )) when the π * (f ) are small (this is justified by Le Cam's theorem).
Similar approaches may be used to find P(E 2 = l|S) for E 2 = 0, . . . , |B|. However, numerical issues tend to be greater in this case for bioinformatics applications since |B| tends to be much larger than |G|.
Finally, we discuss two important properties of OBFMs in Appendix B: asymptotic normality and consistency. Although OBFMs internally assume independent Gaussian features, these properties still hold, and simulations show that they also have excellent performance, even when used with correlated non-Gaussian data.
IV. SYNTHETIC DATA PERFORMANCE ANALYSIS
In this section, we present several synthetic data simulations to compare OBFMs with error moment approximations based on Bayesian variable selection methods in the literature, compare OBFM-based FDR estimation with several methods of FDR control, and compare OBFMs with stability indices.
A. COMPARISON BETWEEN BAYESIAN VARIABLE SELECTION METHODS
We generate data using a Gaussian model with correlation presented in [61] with |F| = 100 total features. We draw |Ḡ| = 10 good features uniformly from the set of all feature sets of size 10 (which determines bothḠ andB). A feature partition for good features is drawn uniformly from the set of all partitions ofḠ containing two blocks of size five, and a feature partition for bad features is drawn uniformly from the set of all partitions ofB containing eight blocks of size five and five blocks of size ten. Once the features have been partitioned into blocks, the mean and covariance matrix for class y in each good block A are drawn from a normalinverse-Wishart(S A y , κ A y , m A y , ν A y ) distribution, and the mean and covariance matrix for both classes in each bad block A are
, where I k×k is the k-by-k identity matrix and 1 k×1 is the k-by-1 all one vector. Using these means and covariances, we generate a Gaussian sample of size n with an equal number of points in each class. We then select the ten features with smallest Welsch t-test p-values. We observed similar trends in performance using other selection rules, thus here we report results for t-test only. The sampling procedure is iterated 2, 000 times for each sample size from 40 to 200 in steps of 20.
Given data and a selected feature set, the task is to perform error analysis; that is, the algorithms we will compare here all aim to predict the number of features erroneously selected (E 1 ) and the number of features erroneously not selected (E 2 ). We will implement several Bayesian variable selection algorithms to approximate π * (G) or π * (f ), which can then be used with Theorem 1 to obtain first and second moments of E 1 and E 2 . Our goals are to demonstrate the versatility of the general proposed error analysis framework, show how it can be used in conjunction with a wide range of Bayesian models, and compare the performance and computational complexity of error moments obtained from different Bayesian methods, including our own OBFMs.
Exact first and second-order moments for E 1 and E 2 can theoretically be computed using Theorem 1, where π * (f ) and π * (f , f ) are found using (1) and (2), respectively, and the exact π * (G) for our data generation model is provided in [61] . Error moments output by each Bayesian variable selection algorithm we will consider are approximations of these exact moments. Ideally, we would study the discrepancy between approximate moments and their corresponding exact moments. However, under |F| = 100 features, the sums in (1) and (2) are intractable. Instead, we will directly compare approximate moments with E 1 and E 2 .
We approximate error moments using two OBFMs: OBFM-PP and OBFM-JP. Both (incorrectly) assume independent Gaussian models. PP and JP refer to the family of hyperparameters used. OBFM-PP uses a proper prior related to the true data generation model with the following hyperparameters for all f : π(f ) = 10/100, s
, and K 's and L's given by (16) and (17) . OBFM-JP uses Jeffreys' non-informative prior:
(since the ν's are zero, we need not specify the m's). OBFM-JP simplifies considerably; by (18) 
Here, we set A f = 0.05/9. The marginal posterior is then given by
We also approximate error moments using four Bayesian variable selection methods in the literature: SKBS [40] , BPM [33] , the method of [51] , hereafter called Bayesian subset regression (BSR), and generalized linear models using the BayesReg package [56] in MATLAB. See Appendix C for more details about our implementations. We present performance for several variants of each method: SKBS-1, SKBS-10, BPM-1, BPM-10, BSR-1 (γ = 0), BSR-10 (γ = 0), logit-HS-2 and logit-HS-20. SKBS-1, BPM-1, BSR-1 and logit-HS-2 are omitted when they perform similarly to SKBS-10, BPM-10, BSR-10 and logit-HS-20, respectively. Fig. 3 plots the average and RMS of E(E 1 |S) − E 1 and E(E 2 |S) − E 2 for each error mean approximation method. Note two facts. First, letÊ 1 (S) be any approximation of E(E 1 |S). By the law of total expectation,
This is also a consequence of the unbiasedness of E(E 1 |S) in (10) . The left-hand side is the quantity estimated in Fig. 3(a) , and the right-hand side is the average difference between error mean approximations and the exact error means that are computationally intractable. In other words, deviations from zero in Fig. 3 (a) are due to inaccuracy or imprecision in the first moment approximations relative to the exact first moments. Second, let E and P denote expectation and probability in the true data generation model. Consider an independent Gaussian model with hyperparameters that assign ''correct'' priors to individual features. This is precisely OBFM-PP in the current simulation. Let E OBF and P OBF denote expectation and probability in the OBFM model, and let S f denote the portion of the sample corresponding to feature f . Under filter-based selection rules like t-test,
In the second line, we condition on S f instead of S because features are independent in the OBFM model, and here we use a filter-based selection rule. The third line follows because the marginal distribution of S f under E and E OBF are equivalent. The fourth line follows because the marginal prior probability of f being a bad selected feature is the same under P and P OBF . Thus, the OBFM error mean approximation is theoretically equivalent to the exact error mean on average over the true sampling distribution. By (29) and (30), the OBFM-PP curve estimated in Fig. 3(a) is theoretically equal to zero. Similar results hold for E 2 in Fig. 3(c) .
To help understand which algorithms are performing well in Fig. 3 , and which are not, note that E 1 is bounded between 0 and 10, and error mean approximations are bounded between 0 (if π * (f ) = 1 for all f in (5)) and 10 (if π * (f ) = 0 for all f ) in this simulation. If one were to approximate E(E 1 |S) by the constant 5, irrespective of the data and feature selection rule, then the absolute difference between E 1 and this approximation would be upper bounded by 5. Any method not between −5 and 5 in Fig. 3 (a) or above 5 in Fig. 3(b) should thus be avoided. These bounds hold across all sample sizes for all methods in Figs. 3(a) and (b), except BPM-10, which deviates farther from 0 as sample size increases. Likewise, E 2 is bounded between 0 and 10 because ten features are selected, so we expect a good approximation of E(E 2 |S) to have the same bounds. However, error mean approximations computed from (7) can be far larger, ranging between 0 (π * (f ) = 0 for all f ) and 90 (π * (f ) = 1 for all f ). Approximating moments for E 2 is typically more difficult than approximating moments for E 1 , in part because E 1 involves a sum over |G| = 10 terms, while E 2 involves a larger sum over |B| = 90 terms. Aside from logit-HS=2, logit-HS-20 and SKBS-10, the average difference curves in Fig. 3(c) range between roughly −5 and 5, and the RMS curves in Fig. 3(d) range between roughly 0 and 5 for all sample sizes, as expected. logit-HS-2 and logit-HS-20 at least appear to improve as sample size increases, while SKBS-10 has the worst average difference and RMS for E 2 , which appears almost flat with respect to sample size.
OBFM-PP and OBFM-JP enjoy the smallest average absolute difference and smallest RMS among all methods in almost all settings, with OBFM-PP having lower RMS than OBFM-JP, and, as expected, OBFM-PP always being unbiased for all sample sizes. One exception occurs in a small window of sample sizes from about n = 70 to 100, where logit-HS outperforms OBFM-JP in Fig. 3(a) . However, one may not know this range of n in practice, and logit-HS has much larger RMS than OBFM-JP over the whole range of sample sizes. Overall, these results suggest that OBFMs provide the most reliable error moment approximations among methods shown. OBFM-JP underestimates E 2 , with comparable performance to that of BSR-1 and BSR-10 under small samples, and slightly better performance relative to BSR-1 and BSR-10 as sample size increases. Correspondingly, the RMS of OBFM-JP is somewhat larger than the RMS of OBFM-PP in Fig. 3(d) , especially for small sample sizes.
After the OBFM methods, BSR-1 and BSR-10 are the next best performing methods for E 1 under small samples and E 2 across all sample sizes. When it comes to approximating E(E 1 |S), BSR-1 outperforms BSR-10, even though it uses fewer MCMC samples. BSR is initialized with the t-test feature set, and we observed that the BSR MCMC samples deviate farther from this feature set as the chain evolves. On the other hand, BSR-1 and BSR-10 produce similar approximations of E(E 2 |S).
After the OBFM methods, SKBS-10 is the next best performing method for E 1 under large samples in terms of RMS, although it should not be used when approximating E(E 2 |S). SKBS-10 seems to assign large posteriors to all features, whether they are inḠ or not, which tends to result in small E 1 moment approximations and very large E 2 moment approximations. (In general, when E 1 moment approximations are high-biased, the corresponding E 2 moment approximations tend to be low-biased, and vice-versa.) This behavior was also observed in [27] . Although it was shown in [40] that SKBS is asymptotically consistent under its modeling assumptions, our simulations suggest that the error moments produced by SKBS may require unfeasibly large sample sizes to produce reliable approximations of E(E 2 |S).
logit-HS-2 and logit-HS-20 produce approximations of E(E 1 |S) within the bounds discussed above, which tend to underestimate E 1 under small samples and overestimate E 1 under larger samples, eventually producing approximations like those of BSR-1. Note that BSR-1 is initialized with the t-test feature set, while logit-HS is not. logit-HS should be avoided when approximating E(E 2 |S).
Finally, in all parts of Fig. 3 , BPM-10 appears to produce error moment approximations with performance curves very close to the bounds discussed above. In other words, while it does not catastrophically fail in this example, in all cases we observed that it also does not outperform the trivial rule that approximates the error means by the constant 5.
We now focus on second order moments. Fig. 4 plots the signed square root of the average and square root of the RMS of E(E 2 1 |S) − E 2 1 , E(E 2 2 |S) − E 2 2 and E(E 1 E 2 |S) − E 1 E 2 for each error mean/variance approximation method, where the signed square root of x ∈ R is defined to be sign(x) √ |x|. We find E(E 2 1 |S) = var(E 1 |S) + (E(E 1 |S)) 2 by plugging in the same E(E 1 |S) used in Fig. 3 and computing var(E 1 |S) .
LetŜ 1 (S) be an approximation of E(E 2 1 |S). Again, by the law of total expectation,
A similar result holds for E 2 2 and E 1 E 2 . Thus, deviations from zero in the signed root average difference curves in Fig. 4 are due to inaccuracy or imprecision in the second moment approximations relative to the exact second moments.
E(E 2 1 |S) is bounded between 0 and 100. A rule that approximates E(E 2 1 |S) by the constant 50 must range between −7.1 and 7.1 in Fig. 4(a) , and between 0 and 7.1 in Fig. 4(b) . The same bounds hold for E 2 2 and E 1 E 2 in the rest of Fig. 4 . All curves shown in Fig. 4 are within the expected bounds except: BPM-10 far overestimates E(E 2 1 |S) in (a) and (b), SKBS-10, logit-HS-2 and logit-HS-20 far overestimate E(E 2 2 |S) in (c) and (d), and SKBS-10 far overestimates E(E 1 E 2 |S) in (e) and (f). These algorithms should be avoided in these cases.
As before, OBFM-PP has the lowest RMS and is nearly unbiased, and OBFM-JP has the next lowest RMS throughout Fig. 4 . Thus, OBFM-PP and OBFM-JP provide the most accurate second order estimates among methods shown. In general, our observations for other algorithms in Fig. 3 also apply to the analogous parts of Figs. 4(a)-(d) . The mixed second order moments in Figs. 4(e) and (f) are interesting. In terms of the RMS, after OBFMs the best performing methods are BSR-10 and BSR-1, which are closely followed by BPM-10, then logit-HS-2 and logit-HS-20, and finally SKBS-10 exceeds the desired bounds. Although BSR and logit-HS appear nearly unbiased over a small window of sample sizes, and less biased than OBFM-JP overall, they have significantly worse RMS than OBFM-JP across all sample sizes.
Let us now turn our attention to asymptotic normality. Let
var(E 1 |S). For each error moment approximation method, we obtain an approximate Z-score by replacing the exact error mean and variance with their approximations in Z 1 . Fig. 5 presents QQ plots of approximate Z-scores versus the standard normal distribution, when n = 40 and n = 100. Apart from logit-HS-20, all QQ plots appear fairly linear, suggesting that these Z-score approximations are all nearly normal. In fact, the OBFM-PP approximate Z-score is nearly standard normal, and that of OBFM-JP is nearly non-standard normal with a mean of about −1 and nearly unit variance. The asymptotic normality proof in Appendix B-A suggests that Z-scores under OBFMs are approximately normal (under large |F| given a fixed sample) under certain mild conditions. These conditions are satisfied here, except that features are dependent (because |Ḡ| is fixed and because we group features into correlated blocks). Although not shown, we also observed that OBFM approximate Z-scores tend to become heavier tailed as sample size increases, and we observed similar trends overall for E 2 and E t , and for other feature selection rules. We next use the marginal posteriors from each algorithm in (27) and (28) to approximate P(E 1 = l|S) for all l = 0, . . . , 10. These equations only hold for independent models (OBFM and SKBS), but we still use them with the other methods because the general equation in (3) is not Note that E 1 takes on only integer values; we use the spline method in the MATLAB function interp1 to interpolate points. OBFM-PP seems to be the least biased estimate, while OBFM-JP slightly overestimates E 1 . BSR-1 is the next best performing, followed by BSR-10, which are both high-biased. logit-HS-2 and logit-HS-20 tend to be very similar to each other, and while they are low-biased in part (a), they shift mass right and appear more bimodal as sample size increases in part (b). In both parts (a) and (b), BPM-10 seems very high-biased, only assigning large probabilities to large E 1 's, while SKBS-10 seems low-biased. Now consider an approximation of P(E 1 = l|S) where we estimate the PMF at each l with a Gaussian PDF with mean E(E 1 |S) and variance var(E 1 |S) evaluated at l. If the features were independent, our proof of asymptotic normality suggests that this would be a good approximation for E 1 when |F| is large. Figs. 6(c) and (d) present the average difference between P(E 1 = l|S) computed using the Gaussian approximation and the exact independent Gaussian model equations (we show the approximate value minus the exact value), both with respect to l for n = 40 and 100. In these graphs we use linear interpolation. Only OBFM-PP and OBFM-JP are shown. The Gaussian approximation seems more accurate for n = 40 than n = 100. As n increases, the marginal posteriors π * (f ) tend to converge to 0 (for f ∈Ḡ) or 1 (for f / ∈Ḡ), and they tend to converge even faster under OBFM-PP than OBFM-JP. As the probability of success of a Bernoulli random variable deviates from 0.5, its absolute skewness and kurtosis increase, which suggests that a larger sum of such random variables is necessary for the central limit theorem to be adequately accurate. Both plots suggest that the Gaussian approximation may be satisfactory (within ±0.02) for OBFM-PP and OBFM-JP in many applications.
Finally, Table 1 provides the relative running time of all methods implemented in this section, averaged over 10 iterations, for n = 40 and 100. OBFM for n = 100 is taken as the unit of time (OBFM-PP and OBFM-JP had similar running times, i.e., OBFM's running time does not depend on the prior). OBFM is orders of magnitude faster than all other Bayesian methods. The running time of BSR includes all γ 's tested. While sample size does not affect the running time of OBFM much, all other algorithms seem more affected. The reason for OBFM's advantage is that it enjoys a closedform posterior, while all other methods require MCMC. In addition, OBFMs perform well under very large |F|, but these results are omitted because the other Bayesian methods cannot be implemented under very large |F| for comparison.
B. COMPARISON WITH FDR CONTROL
Here we use OBFMs to estimate the FDR of a given feature set, and compare this approach with several methods of FDR control. Although OBFMs can estimate the FDR for any arbitrary feature set, FDR control only provides performance guarantees on certain sets. For example, BH [11] reports a set with FDR bounded by α, but has no mechanism to report on the FDR of other sets. ST [52] is more flexible than BH in that it assigns a q-value to each feature, so that one can report the FDR associated to each set of top D features; however, it can only be used with sets that are of the form of top D features, and cannot be used for an arbitrary set.
We use the same data generation model as in Section IV-A. In each iteration of each sample size, we implement several feature selection methods that can output p-values: t-test, logit-HS-2, logit-HS-20, and BSR-1 (we only implement γ = 0, since this setting resulted in superior performance in Section IV-A). Along with these, we implement several FDR correction methods, setting α = 0.05 throughout. First, we use BH and ST with p-values from t-test. Then, since the BayesReg package outputs a t-statistic for each feature, which we can convert to p-values, we also use BH and ST with p-values from logit-HS-2 and logit-HS-20. We observed that logit-HS-2 and logit-HS-20 typically report empty feature sets while bounding FDR by 5% under both BH and ST, and hence these results are omitted. Finally, BSR comes with an algorithm to convert marginal posteriors to marginal inclusion scores, which are then converted to q-values using the method of ST for FDR correction [51] .
We thus report three feature sets corresponding to three FDR correction methods: t-test(BH), t-test(ST), and BST(ST). For each feature set, the corresponding FDR estimate is set to the bound α = 5%. Finally, we use OBFM-PP and OBFM-JP to estimate the FDR of each of these three feature sets, for a total of six OBFM-based FDR estimates. Fig. 7 plots the average and RMS of E(Q|S) − Q for each method. For OBFM-based FDR estimates, the set used is indicated in the legend after the slash sign. A conservative estimate of FDR is larger than the FDP on average, i.e., it has positive average difference in part (a). Overall, OBFM-PP outperforms OBFM-JP, and, in this example, both are always conservative estimates with superior or comparable RMS relative to the three basic FDR correction methods (which all estimate FDR by the design bound, 5%). The average difference of t-test(BH) is slightly above zero in part (a), meaning that the average FDP of the selected set is below α = 5%, as desired. OBFM-PP has almost zero average difference on the t-test(BH) set, which is slightly below t-test(BH), and has smaller RMS. Thus, on average, FDR estimates using OBFM-PP are more accurate than the 5% bound on t-test(BH). OBFM-JP is more conservative than OBFM-PP and the 5% bound on t-test(BH), but still has an RMS close to that of the 5% bound on t-test(BH). While t-test(ST) slightly exceeds the 5% bound, OBFM-PP is unbiased on this feature set, OBFM-JP is a bit conservative, and both OBFM methods have superior RMS compared to that of the 5% bound on t-test(ST). BSR(ST) severely violates the desired FDR bound α = 5%, resulting in large negative average difference and high RMS. OBFM-PP and OBFM-JP provide slightly conservative FDR estimates, which also provide smaller RMS than the 5% bound on BSR(ST). 
C. COMPARISON WITH STABILITY INDICES
We again use the data generation model from Section IV-A, except we iterate 1, 000 times. In each iteration, we generate 1, 000 random subsets of the sample using 90% of the data from each class, and for each subset we output the top 100 features using t-test. Among the 1, 000 feature sets reported, we select the feature set corresponding to the largest average stability index relative to other feature sets reported, where here we use the relative Hamming distance stability index given by 1−(|S\S |+|S \S|)/|F| for sets S and S [62] . Since we always select 100 features, relative Hamming distance, Jaccard's index, Dice-Sorensen's index, Ochiai's index, percentage of overlapping features, and Kuncheva's stability index are all equivalent [19] . The performance of this selection rule is close to that of t-test on the full dataset.
In each iteration, we also report the maximum average stability index, corresponding to the selected feature set. To map stability indices to error moments, we partition all iterations into equal-sized training and validation groups. For each iteration in the validation group, we approximate the stabilityindex-conditioned mean and variance of E 1 as follows: we find the five nearest neighbors in the training group with stability indices closest to that of the current validation iteration, and report the mean and variance of E 1 over these five nearest neighbors. This training phase maps indices to error moments, but cannot be implemented in practice because it requires knowing which features are good. Fig. 8 shows the average and RMS of E(E 1 |S)−E 1 for each method. The ''stability index'' line represents the average over validation iterations, and all other lines represent the average over all iterations. OBFM-PP again appears nearly unbiased with lower RMS than OBFM-JP. The stabilityindex-conditioned expectation for E 1 also appears nearly unbiased, with RMS close to that of OBFM-JP. Graphs comparing approximations of E(E 2 1 |S) to E 2 1 are similar to those in Fig. 8 . In general, we observed that stability indices vary from performing as well as OBFM-PP to having performance that degrades as sample size increases. Even though the stability-index-conditioned expectation for E 1 cheats (the training phase knows which features are good), OBFM-PP outperforms, and OBFM-JP performs quite well. 
V. REAL DATA ANALYSIS
Here we present error analyses using BH and OBFM-JP on microarray datasets for breast cancer and colon cancer. We conclude this section with a discussion on the practical issue of choosing A f for OBFM-JP.
A. BREAST CANCER DATASET
Microarray data from [63] is deposited on gene expression omnibus (GEO) [64] with accession number GSE25066 using the GPL96 platform. 1 This data is already normalized, and contains |F| = 22, 283 probes for 111 relapsing breast cancer patients and 397 relapse-free patients. We remove all probes that do not map to genes, which leaves 20, 967 probes that map to 13, 211 different genes.
We select features using several variants of t-test and a variant of OBF that bounds FDR [65] . All variants of t-test first rank probes, then rank genes using the highest-ranking probe mapping to each gene. We use this gene ranking to select D = 500, 1000, 2000 and 3000 genes, and we use BH correction [11] with α = 5% to output a fourth gene set. OBF-FDR-JP ranks genes by the highest-ranking probe for each gene using π * (f ) from an independent Gaussian model with JP and A f = 0.05/9, and selects the top D features where D is the largest value such that FDR = E(E 1 |S)/|G| ≤ α. Although OBF-FDR-JP uses the same gene rank as standard OBF, it uses OBFMs to determine how many features to report given the desired FDR bound. This illustrates one important application of error moment approximations for feature selection.
BH can only evaluate the overall quality of the whole selected set. While it is assured that features with smaller p-values rank higher and contribute less to the FDR, the extent to which each feature contributes to the overall FDR is not easily quantified through q-values. In contrast, OBFMs can be used to validate each feature individually. By inspecting (5) and (7) we see that 1 − π * (f ) and π * (f ) can be interpreted as the amount feature f contributes to the expected errors E(E 1 |S) and E(E 2 |S), respectively. Similarly, from (23) and (24) we see that π * (f )(1 − π * (f )) represents the contribution of feature f to both error variances var(E 1 |S) and var(E 2 |S) in independent Gaussian models. Table 2 lists several genes ranked by t-test and OBF-FDR-JP, along with q-values from t-test with BH, marginal posteriors π * (f ), and the contribution of each gene to the error variances π * (f )(1 − π * (f )) (note that the maximum contribution to variance is 0.5 × 0.5 = 0.25). Features ranked high by t-test typically have large π * (f ) in the independent Gaussian model and are also ranked relatively high by OBF. For instance, in this dataset all 1, 804 genes selected by t-test with BH are among the top 4, 107 genes ranked by OBF. Meanwhile, many features can be ranked high by OBF and missed by t-test, primarily due to differences in variances (e.g., differing subpopulations). For example, APC is ranked second by OBF, but ranked over 2, 000th by t-test. Histograms of expression values for APC under relapse-free versus relapsing cohorts are provided in Figs. 9(a) and (b) ; although the means of these distributions are close, the histogram of relapsing patients has a larger variance, and a notably heavier left-tail. APC has been shown to be affected in breast cancer [66] . While it is unlikely for a breast cancer biomarker to be ranked low by OBF and high by t-test, it is possible for both rules to assign low ranks to important biomarkers. For instance, although MRPL52 has been suggested to be involved in breast cancer in several studies [67] - [69] , it ranks 3, 000th under t-test and 5, 768th under OBF. Histograms of MRPL52 are provided in Figs. 9(c) and (d); it has rather similar distributions in both cohorts. Consequently, MRPL52 has a relatively large q-value and small π * (f ). While this gene may generally be involved in breast cancer, it is possible that it has similar expression profiles in relapsing versus non-relapsing patients, or that it simply does not demarcate between the cohorts in this dataset. Going forward, we refer to differentially expressed genes (''good'' features) as a ''markers,'' and genes that are not differentially expressed (''bad'' features) as ''non-markers.'' TABLE 3. OBFM-JP error moments for several feature selection algorithms in the breast cancer dataset. Table 3 lists OBFM-JP means and standard deviations for each selection algorithm. OBFM-JP uses the same inputs as OBF-FDR-JP and considers only the highest-ranking probe for each gene under OBF-FDR-JP. Under t-test with BH, OBFM-JP predicts 1088 ± 13 (mean ± std. dev.) false discoveries out of 1804 discoveries, or an FDR of 60.3% ± 0.7%. Under OBF-FDR-JP, OBFM-JP predicts 41 ± 6 false discoveries out of 820 discoveries, or an FDR of 5.0%±0.7%. OBFM always predicts that OBF-FDR-JP (using the same input parameters as OBFM) has a mean FDR below, but as close as possible to, α. Further error analysis with OBFM-JP suggests that: (1) the expected number of true markers is E |Ḡ| S ≡ f ∈F π * (f ) = 1277, so the number of markers involved in breast cancer relapses might be large, (2) although OBF-FDR-JP selects less than half as many features as t-test with BH (820 for OBF versus 1804 for t-test), we expect it to select more true markers (E(C 2 |S) = |G| − E(E 1 |S) = 779 for OBF versus 716 for t-test), and (3) the true FDR under t-test with BH is significantly higher than α = 5%, but not far from α under OBF-FDR-JP. Finally, the mean and standard deviation estimates of E 1 , alongside the asymptotic Gaussian distribution result, can be used to report FDX estimates or credible intervals of the true FDP. For instance, for the OBF-FDR-JP gene set, denoted by G OBF , [3.62%, 6 .37%] is the 95% credible interval of true FDR, and P(E 1 /|G OBF | > 7.1%|S) < 1%. While we expect on average 1, 277 total markers in this dataset, we expect on average all but 371, 86, and 33 markers to rank in the top 1, 000, 2, 000, and 3, 000 genes reported by OBF. Estimates of E(E 2 |S) like these can be useful in determining how many features to select during preliminary gene filtering. OBFMs can also be used to study arbitrary sets, for example, OBFM-JP estimates on average 498 − 371 = 127, 498 − 86 = 412, and 498 − 33 = 465 markers among the top 1, 000−820, 2, 000−820, and 3, 000−820 genes not selected by OBF-FDR-JP, and that all but 420 markers rank in the top 3, 000 genes reported by t-test. Similar analyses can be done with any feature set or selection rule. Performing enrichment analysis using PANTHER on the 1, 804 significant genes of t-test with BH, 12 pathways are significant while bounding the FDR of enrichment analysis by 5%. The top-ranking PANTHER pathway is the Gonadotropin-releasing hormone receptor pathway with an adjusted p-value of 5.2 × 10 −4 . Forty-three of the t-test genes map to IDs in this pathway in the PANTHER pathway database. OBFM reports E(E 1 |S) = 38.9 on this set of 43 genes, which suggests that, although the average FDP is bounded by 5%, locally speaking, the set of genes mapping to this pathway may be polluted with many false discoveries. Had we used A f = 0.5/9 instead of 0.05/9 here, which we later argue is too extreme for this dataset, then OBFM would report E(E 1 |S) = 10.6, which would still be too many false discoveries. In contrast, FDR correction with BH cannot provide an FDR estimate for this set.
B. COLON CANCER DATASET
Microarray data from [70] is deposited on gene expression omnibus (GEO) [64] with accession number GSE39582 using the GPL570 platform. 2 This data is already normalized; however, we perform a log normalization step so that the data is more suitable for a Gaussian model. This dataset contains |F| = 54, 675 probes for 315 early-stage (stages 1 and 2) and tumoral colon cancer patients and 270 late-stage (stages 3 and 4) colon cancer patients. We remove all probes that do not map to genes, which leaves 45, 772 probes that map to 23, 520 different genes. We use OBF-FDR-JP and t-test with similar implementations as in the breast cancer dataset analysis, except we set A f = 0.1/9 for OBF-FDR-JP. Table 4 lists several genes ranked by t-test and OBF-FDR-JP. All of the top ten features ranked by t-test are also ranked in the top 150 by OBF, while all of the top ten features ranked by OBF are ranked below the top 1, 000 by t-test. For example, GDF10 and CALCB are ranked first and sixth by OBF, but ranked nearly 2, 000th and 10, 000th by t-test, respectively. Histograms of expression values for GDF10 and CALCB are provided in Figs. 10(a) through (d) , where we observe similar means between early and late-stage cohorts, but distinctly heavier right-tails (subpopulations with higher expression) in the early-stage cohort for GDF10 and in the late-stage cohort for CALCB. In the literature, both GDF10 [71] , [72] and CALCB [73] , [74] have been suggested to be affected in colon cancer. 2 Accessed on December 14, 2018. Table 5 lists OBFM-JP means and standard deviations for each selection algorithm. Under t-test with BH, OBFM-JP predicts 2813 ± 20 false discoveries out of 4096 discoveries, or an FDR of 68.7% ± 0.5%. Under OBF-FDR-JP, OBFM-JP predicts 41±6 false discoveries out of 829 discoveries, or an FDR of 4.9% ± 0.7%. Note that [3.52%, 6 .27%] is the 95% credible interval of true FDP, and P(E 1 /|G OBF | > 7%|S) < 1%, where G OBF is the OBF-FDR-JP gene set. Although OBF-FDR-JP reports about one-fifth as many genes as t-test with BH (4, 096 for t-test versus 829 for OBF), we expect it to report more than half as many markers (1, 283 for t-test versus 788 for OBF). To understand one reason why OBFM-JP predicts such a high FDR for t-test, consider the gene IP6K1. Histograms of expression values for this gene under the early versus late-stage cohorts are shown in Figs. 10(e) and (f), and appear to be similar. Although this gene is selected by t-test with BH, it is ranked 3, 000th out of 4, 096 selected genes with a q-value of 0.03, which suggests that it is probably not a strong marker. Meanwhile, the marginal posterior for this gene is only π * (f ) = 0.05, i.e., OBFM predicts only a 5% probability that this gene is a marker. VOLUME 7, 2019 Finally, the expected number of markers is E |Ḡ| S = 1718, which suggests there may be a rather large number of markers that can be used to discriminate between early and late-stage colon cancer. We expect all but 329 and 163 markers to rank in the top 2, 000 and 3, 000 genes reported by OBF, and all but 707 and 552 markers to rank in the top 2, 000 and 3, 000 genes reported by t-test, on average. Performing enrichment analysis using PANTHER on the 4, 096 significant genes from t-test with BH, the top-ranking pathway, p53, has an adjusted p-value of 7.9 × 10 −2 . Twenty-nine t-test genes map to IDs in this pathway in the PANTHER pathway database. OBFM reports E(E 1 |S) = 27.5 on this set of 29 genes, suggesting that, although the average FDP is bounded by 5%, the set of genes mapping to this pathway may be polluted with many false discoveries. Had we used A f = 1/9 instead of 0.1/9, which we later argue is too extreme for this dataset, OBFM would report E(E 1 |S) = 25.2, which is still too large. Genes with small posteriors here can still be affected in colon cancer; it is entirely possible that the current dataset simply does not provide enough evidence to demonstrate this fact.
C. THE CHOICE OF A f
Although the choice of A f has been discussed to some extent in [65] , and thanks to consistency this issue diminishes as sample size increases, the choice of A f remains an important practical issue that can have a significant impact on the marginal posteriors, π * (f ). Here, we discuss the effect of this parameter on our real data analyses.
While it is possible to set A f to different values for different f , throughout this work we assume A f is constant across all features. A f is a scalar comprised of two components:
= 0.05/9 in the breast cancer dataset is consistent with setting π(f ) = 0.1 (a prior assumption that one out of ten genes is a marker) and W = 0.05. However, it is also consistent with many other π(f ) and W pairs. Likewise, A f = 0.1/9 in the colon cancer dataset is consistent with π(f ) = 0.1 and W = 0.1. For comparison, [65] reported that the optimal W for OBF-FDR-JP fell between 0.001 and 2 across 1, 000 iterations in a model with block-diagonal covariance matrices when |Ḡ| is known, π(f ) = |Ḡ|/|F|, and the sample size is 200 in each of two classes. Fig. 11 plots histograms of ln(h(f )) for all probes mapping to genes for our breast cancer and colon cancer datasets. These histograms are calibrated with the default values of A f listed above, and points beyond ln(h(f )) = 10 are not shown. In our framework, ln(h(f )) = 0 corresponds to π * (f ) = 0.5, e.g., the point where a gene is equally likely to be a marker or non-marker. We denote this point by a vertical red line. Features with smaller ln(h(f )) (to the left of the red line) are more likely to be non-markers, while features with larger ln(h(f )) (to the right) are more likely to be markers.
If we increase (decrease) A f by a factor of 10, this graph shifts to the right (left) by ln (10) , which effectively shifts the threshold where π * (f ) = 0.5 to the left (right). Vertical blue and purple lines show the effective threshold for π * (f ) = 0.5 when we increase and decrease A f by an order of magnitude, respectively. An increase in A f results in larger π * (f ), and tends to result in declaring more features as markers.
In the breast cancer dataset, CDC123 is ranked 360th by t-test with a q-value of 3.4 × 10 −3 , and ranked 1, 000th by OBF with π * (f ) = 0.63 when A f = 0.05/9 (the red vertical line). The fact that this gene has a relatively low q-value suggests that there are distributional differences between expression values for this gene under the relapse-free and relapsing cohorts. Thus, π * (f ) for this gene should probably not be too low; setting A f = 0.005/9 (the purple vertical line) gives π * (f ) = 0.15, which is perhaps too small. Now consider the gene GUSBP3, which is ranked 6, 419th by t-test with a q-value of 0.33, and ranked 1, 500th by OBF with π * (f ) = 0.24 when A f = 0.05/9. We found no statistically significant differences for this gene under t-test (p-value = 0.16), a Wilcoxon rank-sum test (p-value = 0.61), and a Kolmogorov-Smirnov test (p-value = 0.55), even without multiple testing correction. Thus, π * (f ) for this gene should probably not be too high; setting A f = 0.5/9 (the blue vertical line) for this gene gives π * (f ) = 0.76, which is perhaps too large. In summary, we believe a moderate value of A f = 0.05/9 achieves a reasonable balance in the breast cancer dataset.
In the colon cancer dataset, SP1 is ranked 309th by ttest with q-value 1.3 × 10 −3 , and 951st by OBF with π * (f ) = 0.73 when A f = 0.1/9. This gene is significant with t-test when bounding FDR by 5%, and we also found evidence of distributional differences between the early and late-stage cohorts using a Kolmogorov-Smirnov test (p-value = 1.1 × 10 −6 ). Setting A f = 0.01/9 gives π * (f ) = 0.24, which may be too small for a differentially expressed gene. For THUMPD1 (ranked 7, 697th by t-test with q-value 0.14, and 1, 766th by OBF with π * (f ) = 0.35 when A f = 0.1/9), we found no statistically significant differences under t-test (p-value = 0.045), a Wilcoxon rank-sum test (p-value = 0.11), and a Kolmogorov-Smirnov test (p-value = 0.09). These p-values do not account for multiple testing. Setting A f = 1/9 for this gene gives π * (f ) = 0.84, which may be too large for a gene with similar distributions between cohorts. Thus, we believe A f = 0.1/9 is a reasonable choice overall for the colon cancer dataset.
If we decrease or increase A f by an order of magnitude in the breast cancer dataset, OBF-FDR-JP would select 467 and 1, 471 genes, respectively, instead of 820. Likewise, if we decrease or increase A f by an order of magnitude in the colon cancer dataset, OBF-FDR-JP would select 415 and 1, 837 genes, instead of 829. In all cases, the number of genes selected by OBF-FDR-JP is well below the number of genes selected by t-test with BH. This suggests that our OBF-FDR-JP analyses may be, if anything, conservative. In other words, the A f used are possibly somewhat smaller than they should be, making the π * (f ) smaller, the estimate E(E 1 |S) for fixed feature sets larger (and the E(E 2 |S) smaller), the FDRs reported using OBFM-JP larger, and the set output by OBF-FDR-JP smaller. If this is the case, the bound FDR ≤ α should still hold, though perhaps with some slack.
Since OBFM tends to report smaller E(E 1 |S) under conservative (smaller) A f , there is some concern that the E 1 means reported in Tables 3 and 5 are overestimates, particularly for t-test. If we increase A f for the breast cancer dataset so that OBF-FDR-JP selects the same number of features as t-test with BH (1, 804 genes), then OBFM still predicts a rather large FDR of 24.9% ± 0.8% for t-test with BH, and an FDR of 5.0% ± 0.7% for OBF-FDR-JP. Similarly, if we set A f so that OBF-FDR-JP selects 4, 096 genes (the same as t-test with BH) in the colon cancer dataset, then OBFM predicts an FDR of 12.2% ± 0.5% for t-test with BH, and an FDR of 5.0% ± 0.5% for OBF-FDR-JP. In both cases, t-test with BH is still expected to have a higher FDR than OBF, and an FDR that far exceeds α. On average, OBF selects more good features (resulting in a lower FDR) than t-test when the number of selected features is held constant under synthetic microarray data models [26] , [27] , as well as under synthetic models that violate the assumptions of OBF [28] .
We close with an analysis of control probes (known nonmarkers). The breast cancer dataset contains 68 control probes. If we include these in our analysis as if they each map to distinct genes, the total number of genes increases to 13, 279. t-test with BH selects 1, 805 genes, of which three correspond to control probes, and OBF-FDR-JP with A f = 0.05/9 outputs the same 820 genes selected in our original analysis. In particular, none of the genes selected by OBF-FDR-JP correspond to control probes, and the highestranking control probe under OBF-FDR-JP ranks 1, 613th. Our conservative value for A f safeguards against declaring noise in the data as significant. In the colon cancer dataset, adding 62 control probes to the analysis effectively increases the total number of genes to 23, 582. t-test with BH outputs 4, 161 genes, of which 42 map to control probes (at least 1.0% false discoveries), and OBF-FDR-JP outputs 867 genes, of which 32 map to control probes (at least 3.7% false discoveries). The large number of control probes selected by both OBF and t-test suggests that relatively small values of A f may be needed in the colon cancer dataset to guard against noise, batch effects, and other possible distortions in the data.
VI. CONCLUSION
The proposed Bayesian framework is designed with biomarker discovery in mind. The overarching goal is to identify and validate all potential biomarkers that exhibit distributional differences between groups. This is distinct from the goals of classical feature selection, which generally aim to reduce dimensionality for the purposes of model construction. Although we focus on biomarker discovery, the validation techniques proposed herein are suitable in any application where the objective is to obtain a comprehensive list of all potentially relevant features.
Simulations show that OBFMs can serve as excellent approximations of error moments for validation. They typically perform at least as well as other validation methods we have examined, they can be easily used with any feature selection rule, and they do not require withholding any data for training. Although in this work we have focused on first and second order moments of errors and the full sampleconditioned PMF of errors, the Bayesian framework can also be used to find higher order moments and credible intervals.
OBFMs require several input hyperparameters that may be difficult to set in practice. When using non-informative priors, A f is a particularly tricky parameter since: (1) it has no operational definition, i.e., no physically meaningful interpretation, and (2) it scales h(f ), and therefore can have a significant impact on the posterior [65] . The consistency proof in Appendix B-B mitigates this problem by guaranteeing that OBFMs converge to their correct values as sample size increases, even when A f is chosen poorly (or other assumptions in the Bayesian model are false, for example when features are non-Gaussian and correlated). Future work will study the robustness of OBFMs under different priors, different methods of prior construction, and different A f calibration policies.
There is also much work to be done in studying validation methods that account for correlations between features. For example, it may be possible to extend feature selection methods that approximate π * (f ) under general models with correlation, like POFAC and SPM [61] . However, validation is inherently harder than feature selection itself-the former requires approximating the values of the marginal posterior probabilities π * (f ), while the latter, assuming the number of features to select is pre-specified, requires only ranking the π * (f ). It is even more difficult to develop suitable methods to approximate var(E 1 |S), var(E 2 |S) and cov(E 1 , E 2 |S), which also require new techniques to approximate π * (f , f ). Unsupervised Bayesian feature selection and validation in the proposed framework are also interesting open problems. In addition, it is possible to inform the Bayesian model with prior scientific knowledge, for example an algorithm that accounts for correlations can use prior knowledge about known markers and known non-markers to improve validation for the other features [75] . Section II of this manuscript provides the basic theory needed to frame all of these problems.
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APPENDIX A
Here we prove Theorem 1. To show (7), observe that
Similarly, (5) holds using P(f ∈B|S) = 1 − π * (f ). Also, (8) holds since var(E 2 |S) = E(E 2 2 |S) − E 2 (E 2 |S), and
Equation (6) follows using similar steps with
APPENDIX B
Here, we discuss two important properties of OBFMs: asymptotic normality and consistency.
A. ASYMPTOTIC NORMALITY
Asymptotic normality is important to justify Gaussian approximations of P(E 1 = l|S). Consider a sequence of selection problems that starts with one feature indexed by f = 1, and iteratively augments the previous sample with one new feature indexed by f = 2, 3, . . .. Let S f denote the sample corresponding to feature f . Assume the selection rule filters features independently based on their corresponding sample and that the same rule is used for all features across all iterations. Assume a ''true'' Bayesian model that assigns each feature to eitherḠ orB independently, and that generates the sampling distribution and sample for each feature independently.
In iteration i, the number of bad features selected can be written as E i
. . , i are mutually independent. Denote the posterior mean and variance of 1 f ∈B∩G by µ f (S f ) and σ f (S f ), respectively, and note that both are always finite. Since the indicators are uniformly absolutely bounded, the Lindeberg condition holds if and only if
. We assume this limit holds with probability 1 (over the sampling distribution); this is true if each feature is generated from the same prior, since the σ f (S f ) become independent and identically distributed with positive finite mean. By the Lindeberg central limit theorem, as i → ∞,
converges in distribution to standard normal. In iteration i, suppose we find OBFMs E(E i 1 |S i 1 ) and var(E i 1 |S i 1 ) using an independent Bayesian model where the prior used for each feature is fixed across iterations (they need not be the same for each feature). Consider the Z-score Convergence holds conditioned on the sample (with probability 1) as the number of features goes to infinity. The assumptions are relatively mild; features in the true Bayesian model are independent, but not required to be Gaussian or to have normal-inverse-Wishart means and variances. Similar proofs hold for Z-scores of E 2 and E t .
B. CONSISTENCY
Loosely speaking, here we show that E(E 1 |S) converges to E 1 , E(E 2 |S) converges to E 2 , and that convergence does not require independence or Gaussianity. This helps justify the use of OBFMs for validation, even when their modeling assumptions (for instance, independence and Gaussianity) are known to be very inaccurate.
Up to this point, we have fixed the sample and considered G and the sampling distribution to be random. Now suppose we fixḠ and the sampling distribution, and let sample size go to infinity. In [27] it was shown that π * (f ) → 1 (with probability 1) for all f ∈Ḡ and π * (f ) → 0 (with probability 1) for all f ∈B as n → ∞ if: (i) The mean and variance of each feature in both classes exist, and fourth order moments for bad features exist. (vi) π * (f ) is computed from an independent Gaussian model with 0 < π(f ) < 1 for all f , where the same set of π(f ), prior hyperparameters, and scaling constants are used for all sample sizes. The following holds for any OBFM satisfying (vi) under any data satisfying (i)-(v). These conditions are very mild; they hold even when the data generating process is correlated and non-Gaussian.
Suppose we find OBFMs using π * (f ) from an independent Gaussian model. For any feature selection rule (we do not require E 1 to converge for this rule), the convergence of π * (f ) with probability 1 over the sampling distribution guarantees that lim n→∞ E(E 1 |S) − E 1 = 0 with probability 1, i.e., E(E 1 |S) is a strongly consistent estimator of E 1 . Likewise, E(E 2 |S) − E 2 → 0 with probability 1. Further, since π * (f , f ) = π * (f )π * (f ) for f = f and π * (f , f ) = π * (f ), we also have that π * (f , f ) → 1 (with probability 1) when f , f ∈Ḡ and π * (f , f ) → 0 (with probability 1) if either f ∈B or f ∈B. Therefore, var(E 1 |S) → 0 and var(E 2 |S) → 0 with probability 1 as sample size goes to infinity.
APPENDIX C
Here we provide details about our implementation of the Bayesian variable selection methods used in Section IV.
SKBS assumes there exists a list of K kernels that compose the class-conditioned distributions for all features. Thereby, distributional differences boil down to having different mixture weights between the two classes. It uses Gibbs sampling to approximate posteriors. We implement a burn-in period of 1, 000 iterations, as suggested in [40] . Although [40] suggests a sampling period of 5, 000 iterations, here we implemented sampling periods of 1, 000, 5, 000, and 10, 000 iterations, denoted by SKBS-1, SKBS-5, and SKBS-10, respectively. We observed little difference in the outputs of SKBS-1, SKBS-5, and SKBS-10, and hence omitted SKBS-5 from all results. While [40] also suggests a method to tune K , we tested several values of K and observed best results when K = 2, which is consistent with observations in [27] . Therefore, we only report results for K = 2 here. Like OBF, SKBS is a filter that assumes features are independent, and outputs an estimated marginal posterior probability for each feature, which we directly substitute for π * (f ). We also use (23) and (24) to approximate π * (f , f ).
BPM assumes a generalized linear model with a probit link and a slab-and-spike prior on regression coefficients. As the posterior does not exist in closed form, MCMC with Gibbs sampling was used in [33] with a burn-in period of 10, 000 iterations and a sampling period of 50, 000 iterations. To keep the computation cost reasonable, here we initialize BPM with the t-test feature set and forgo the burn-in period. We also implement sampling periods of 1, 000 and 10, 000 iterations, denoted by BPM-1 and BPM-10, respectively. We set π * (f ) to the ratio of iterations that output a set containing feature f , i.e., the posterior inclusion probability, and set π * (f , f ) to the ratio of iterations that output a set containing both f and f . BSR assumes a generalized linear model with logit link, and assumes each feature is present in the regression model with probability 1/(1 + √ 2π|F| γ ) for some γ > 0. It uses a stochastic approximation Monte Carlo (SAMC) algorithm to sample the posterior, and proposes an extension for high-dimensional problems. Here we implement the highdimensional variation and allow at most K = 2 × |Ḡ| = 20 features in the models explored by the MCMC. Like BPM, we initialize BSR with the t-test feature set, forgo the burnin period, and use 1, 000 and 10, 000 sampling iterations, denoted by BSR-1 and BSR-10, respectively. While [51] suggests a method of determining γ based on a given dataset, here we implemented all values of γ ranging from 0 to 2 in steps of 0.05, and in each figure, for each sample size, report the result for the optimal γ . Although optimizing γ in this way is not possible in practice and is meant to give an optimistic result for BSR, we observed that γ = 0 is always optimal for both BSR-1 and BSR-10 across all sample sizes. Other parameters of the algorithm are set as suggested in [51] . In Section IV-A we use the raw BSR sampling chain outputs to approximate π * (f ) and π * (f , f ), similar to our approach with BPM, and in Section IV-B we examine the FDR correction method proposed in [51] along with this algorithm.
Finally, we implemented generalized linear models with logit link and horseshoe and LASSO penalties using BayesReg. We observed that the logit model with horseshoe penalty provides more accurate error estimates when compared with the logit model with LASSO penalty, and hence only report results for the horseshoe penalty. By default, BayesReg assumes burn-in and sampling periods of 1, 000 iterations. We increased the burn-in period to 10, 000 iterations, and use 2, 000 and 20, 000 sampling iterations, hereafter denoted by logit-HS-2 and logit-HS-20, respectively. Note that BayesReg samples the regression coefficients, and tends to report non-zero regression coefficients for all features in all sampling iterations. However, the package itself contains a function, br-sparsify, to infer a sparse set of regression coefficients based on the MCMC samples. We used this function with the savs option to infer a sparse set of regression coefficients, and normalized all regression coefficients by the difference of sample means in both classes, for both the inferred sparse set and the MCMC samples. We then used the smallest non-zero normalized absolute coefficient of br-sparsify as a threshold to infer sparse normalized coefficients of the MCMC samples. The features remaining in each MCMC iteration were used as the set of features suggested by the iteration. We then used a similar approach as in BPM and BSR to approximate π * (f ) and π * (f , f ).
